• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 2420-0500
Device Problems Fluid/Blood Leak (1250); Material Separation (1562)
Patient Problems Patient Problem/Medical Problem (2688); No Code Available (3191)
Event Type  malfunction  
Manufacturer Narrative
The affected product has been received and the investigation is pending.A follow up report will be submitted once the failure investigation has been completed.
 
Event Description
It was reported that the bottom portion of the pump segment had detached from the tubing causing trastuzumab to leak.The medication squirted in the bed side nurse¿s eye, causing her to proceed with the hospitals protocol to wash her eyes and visit the er.There was no further reported injury to the nurse.
 
Manufacturer Narrative
The customer¿s report of tubing coming apart and leaked was confirmed.During visual inspection it was observed that the silicone segment was completely separated from the lower fitment.Dimensional testing was performed on the silicone segment tubing and fund to be within specification.Further visual inspection of the separated silicone segment end noted retainer ring indentations on the silicone segment showing that the retainer ring had been in place.Visual examination under microscope noted no crush mark to the upper or lower fitment.The ring retainer was not returned with the suspect set.The marking of the silicone segment from where the o-ring indentations separated from the lower fitment appeared to have a gap.Functional testing of the returned set was deemed unnecessary due to a separation in the silicone tubing.The separation of the silicone pumping segment to the lower fitment was caused by a gap at the engagement that allowed the separation to occur.The root cause of the gap and resulting separation is due to incorrect positioning of the components that was not detected by the sensor during assembly.
 
Event Description
It was reported that the bottom portion of the pump segment had detached from the tubing causing (trastuzumab) to leak.The medication squirted in the bed side nurse¿s eye, causing her to proceed with the hospitals protocol to wash her eyes and visit the er.There was no further reported injury to the nurse.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key9200211
MDR Text Key162695115
Report Number9616066-2019-02866
Device Sequence Number1
Product Code FPA
UDI-Device Identifier07613203012430
UDI-Public7613203012430
Combination Product (y/n)N
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/16/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/25/2022
Device Model Number2420-0500
Device Catalogue Number2420-0500
Device Lot Number19076656
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/01/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-